Skip to main
DD
DD logo

DD Stock Forecast & Price Target

DD Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 55%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

DuPont de Nemours's Healthcare & Water segment has demonstrated strong organic sales growth, driven by robust demand in medical packaging and biopharma, positioning the company favorably in these critical industries. The ongoing transition toward new product offerings, as evidenced by the vitality index improvements, is expected to enhance both pricing and volume in the coming years, further solidifying revenue streams. Additionally, anticipated growth in the Electronics & Industrial segment, fueled by advancements in 5G and IoT, underlines the company's potential for significant volume expansion and favorable valuation adjustments as it continues its portfolio transformation.

Bears say

DuPont de Nemours faces a negative outlook primarily due to anticipated delays in synergy realization post-merger, which hampers the company's ability to achieve operational efficiencies and cost savings. Additionally, ongoing weakness in the electronics and construction markets, compounded by a slower recovery in China, poses significant risks to revenue generation in key segments. These factors collectively threaten to undermine the profitability of DuPont’s core business areas, particularly in healthcare and water, which are expected to drive the bulk of its earnings.

DD has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 55% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DuPont de Nemours (DD) Forecast

Analysts have given DD a Buy based on their latest research and market trends.

According to 11 analysts, DD has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $66.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $66.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DuPont de Nemours (DD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.